MAR 26, 2018 7:21 PM PDT

Cells Change Type After Losing One Gene

WRITTEN BY: Carmen Leitch

Tumors tend to consist of a chaotic mix of cells; one area of the tissue will express one set of genes and have different physical properties than other parts of the tumor. Researchers were still surprised to find a bunch of tiny digestive organ parts along with the cells of a lung tumor. Reporting in Developmental Cell, the researchers found that these cells had lost a regulatory gene that helps determine cell type. When the cells could not turn into lung cells, they went for the closest available type in the developmental line, cells of the gut. 

Staining for specific transcription factors reveals that this lung tumor also includes cells characteristic of the duodenum and intestine. New research from Duke has found that some lung cancer cells with errors in transcription factors begin to resemble their nearest relatives - the cells of the stomach and gut. / Credit: Tata Lab, Duke University

Lead researcher of this work, Purushothama Rao Tata Ph.D., has spent years studying how cells regenerate after injury, and the developmental flexibility they can employ. He wondered if any of these processes applied to tumor cells. He turned his attention to non-small cell lung cancer, a leading cause of cancer deaths around the world. 

The Cancer Genome Atlas Research Network contains genomic data from thousands of samples taken from 33 different kinds of cancer, which Tata utilized for his work. He determined that many tumors from non-small cell lung cancer did not express Nkx2.1, a gene that sends cells to their fate as part of the lung. The tumors were expressing genes that have been linked to esophageal and gastrointestinal organs instead.

"Cancer cells will do whatever it takes to survive," said Tata, an assistant professor of cell biology at Duke University School of Medicine and Duke Cancer Institute member. "Upon treatment with chemotherapy, lung cells shut down some of the key cell regulators and pick up the characteristics of other cells in order to gain resistance."

That led Tata to hypothesize that when lung tumor cells lose Nkx2.1, they cease to be lung cells and morph into other types. Lung and gut cells come from the same parent cell type, so it is not a surprising change, even though it seems strange. 

The hypothesis was tested by Tata’s research team by using a mouse model. After deleting the Nkx2.1 gene from only lung cells, structures began to appear like some in the gut. These gastric-like tissues, incredibly, also made digestive enzymes as though they were part of the stomach.

Additional genetic manipulation was performed in the mouse model; the activation of cancer genes SOX2 or KRAS along with the lung cell deletion of Nkx2.1. In the SOX2 mice, tumors appeared that resembled the foregut, while in the KRAS mice, tumors looked like parts of the mid- and hindgut.

In additional work, a mini lung tumoroid system was developed. That enabled the researchers to confirm that genes are enough to change the fate of lung cells. Those cells don’t need signals from the local environment. 

"Cancer biologists have long suspected that cancer cells could shapeshift in order to evade chemotherapy and acquire resistance, but they didn't know the mechanisms behind such plasticity," said Tata. "Now that we know what we are dealing with in these tumors - we can think ahead to the possible paths these cells might take and design therapies to block them."

Tata has plans to continue this work to investigate the mechanisms by which lung cancer cells develop drug resistance.


Sources: AAAS/Eurekalert! Via Duke University, Developmental Cell

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 21, 2020
Cancer
JAN 21, 2020
A gene for leukemia triggers the growth of stem blood cells
New research from the University of Colorado Cancer Center has identified a way to make hematopoietic stem cells from a gene that causes a type of leukemia
JAN 11, 2020
Neuroscience
JAN 11, 2020
Molecular Therapy to Self-Repair Nerve Cells
Neurodegenerative diseases such as Multiple Sclerosis (MS), Alzheimer's, and Huntington's Disease are predicated on damage to myelin on nerve cells
FEB 23, 2020
Genetics & Genomics
FEB 23, 2020
Revealing More About the Genetic Mechanisms Underlying Down Syndrome
Down syndrome impacts around 6,000 live births in the US every year. Around 95% of affected individuals have a type call...
MAR 01, 2020
Genetics & Genomics
MAR 01, 2020
Treating Huntington's Disease With a Gene Therapy That Targets Brain Cells
A new therapeutic approach for Huntington's disease may aid patients with other neurodegenerative disorders.
MAR 24, 2020
Genetics & Genomics
MAR 24, 2020
Crumpling Graphene Makes It an Ultra-Sensitive Biosensor
Liquid biopsies often need to make many copies of RNA or DNA before they are detectable. New research aims to change that.
APR 03, 2020
Neuroscience
APR 03, 2020
Why Autism is More Common in Boys than Girls
Researchers from the National Institutes of Health (NIH) have identified how a change in a single amino acid may be linked to symptoms of autism. In partic
Loading Comments...